We apply iPSC scientific expertise and cell manufacturing experience to cell therapy by designing and delivering iPSC solutions to our partner’s requirements. Offerings include basic research support, process development and large-scale custom manufacturing of a range of cell types.

Ncardia develops and delivers state-of-the-art integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates. Our services are based on fully functional and validated hiPSC-derived cell models that are manufactured under strict quality assurance.